<DOC>
	<DOCNO>NCT02320604</DOCNO>
	<brief_summary>Dosing guideline liposomal amphotericin B ( AmBisome ) ( morbidly ) obese patient available . Subsequently , pharmacokinetic profile AmBisome specific patient population still largely unknown . To build valid pharmacokinetic model , obese patient BMI ≥ 40 undergoing endoscopic gastric bypass surgery receive single dose 2 mg/kg 3 mg/kg AmBisome ( besides standard anti-bacterial prophylaxis ) PK-curve drawn . These PK-values compare pharmacokinetics normal-weight group .</brief_summary>
	<brief_title>Liposomal Amphotericin B ( AmBisome ) Pharmacokinetics Given Single Intravenous Dose Obese Patients ( ASPEN )</brief_title>
	<detailed_description>- The overall trial design prospective , open-label , non-randomized , single-centre , single-dose , multiple dose level trial , ( 2 mg/kg 3 mg/kg ) . - A total sixteen patient BMI ≥40 kg/m2 undergo bariatric surgery receive pre-surgery dose AmBisome 2 mg/kg ( n=8 ) 3 mg/kg ( n=8 ) enrol . - After enrollment group 1 ( 2 mg/kg ) , interim analysis safety AmBisome perform proceed group 2 ( 3 mg/kg ) . - Infusion time concentration AmBisome 60 minuten ( 2 mg/kg group ) 90 minute ( 3 mg/kg group ) - A PK curve determine administration single , pre-surgery dose AmBisome = 0.5 , 1 ( end infusion ) , 1.5 , 2 , 4 , 6 , 8 , 10 , 12 , 24 , 48 ( feasible ) 72 hour post infusion ( n=12 sample ) group 1 ( 2 mg/kg ) , 8 patients.The PK curve group 2 ( 3 mg/kg , 8 patient ) similar group 1 , except t=1.5 hour sample point , end infusion due infusion time 90 minute . - Patients consider complete study least 9/11 sample PK curve 48 hour collect . - Patients select research team good spread weight band .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>1 . Patient BMI ≥40 kg/m2 undergo bariatric surgery 2 . Subject least 18 age day screen . 3 . Subject legal representative able willing sign Informed Consent screen evaluation . 1 . Documented history sensitivity medicinal product excipients similar find polyene preparation . 2 . History , current abuse drug , alcohol solvent ( maximum three month enrolment ) . 3 . Inability understand nature trial procedure require . 4 . Administration nephrotoxic medication ( aminoglycosids , immunosuppressant , antiviral , antineoplastic agent ) maximum one month enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Liposomal amphotericin B</keyword>
	<keyword>AmBisome</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Obesity</keyword>
	<keyword>Bariatric surgery</keyword>
</DOC>